Chronic polypous rhinosinusitis and lung function in the profile of multi-organ pathology in children with cystic fibrosis in the Russian Federation

Chronic rhinosinusitis (CRS), including chronic rhinosinusitis with nasal polyps (CRSwNP), is one of the manifestations of cystic fibrosis (CF). The paranasal sinuses (PNS) are considered as a reservoir of pathogenic microflora and a source of descending infection of the entire respiratory tract. Nevertheless, paranasal sinuses pathology is usually assessed in isolation from both the lower respiratory tract and the entire spectrum of multiple organ damage in CF.

Aim. To determine the prevalence of CRSwNP and its correlation with other characteristics of CF in children in Russia.

Methods. The study included data of 2216 children from 0 to 18 years old from 81 regions of the Russian Federation from the Registry of patients with cystic fibrosis in the Russian Federation for 2018. Children with an established diagnosis of CRSwNP (n = 599) were compared to those without this condition (n = 1 617). The prevalence was assessed in the subgroups by age, sex, respiratory function, nutritional status, microbiological status, complications, the need for various therapies, and the average duration of inpatient treatment during the year. The statistical analysis included parametric and nonparametric tests.

Results. According to the Registry, the average prevalence of CRSwNP among children with CF was 27.03% and tended to increase with age. Children with CRSwNP had statistically significant higher incidence of homozygous F508del mutation, more common intermittent and chronic infection with P. aeruginosa, S. aureus (MSSA and MRSA), cystic fibrosis-associated diabetes mellitus with daily use of insulin, liver damage (as with or without cirrhosis), osteoporosis, a more frequent need for systemic antibacterial and inhalation (except for bronchodilators) therapy, as well as a relatively high need for hospital stay. Unexpectedly, the respiratory function indicators (FEV1, %, FVC, %) and body mass index turned out to be higher in the group of patients with nasal polyposis. A likely explanation is that the study included only children, and the lung function was not analyzed in the children and adolescents.

Conclusion. The results suggest that CRSwNP is a predictor of adverse course of CF and requires attention from CF specialists and otorhinolaryngologists, as well as interdisciplinary collaborations.

1. Schraven S.P., Wehrmann M., Wagner W. et al. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. J. Cyst. Fibros. 2011; 10 (3): 181–186. DOI: 10.1016/j.jcf.2011.01.003.

2. Hansen S.K., Rau M.H., Johansen H.K. et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 2012; 6 (1): 31–45. DOI: 10.1038/ismej.2011.83.

3. Ciofu O., Johansen H.K., Aanaes K. et al. P. aeruginosa in the paranasal sinuses and transplanted lungs have a similar adaptive mutations as isolates from chronically infected CF lungs. J. Cyst. Fibros. 2013; 12 (6): 729–736. DOI: 10.1016/j.jcf.2013.02.004.

4. Aanaes K., Johansen H.K., Skov M. et al. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients – can chronic lung infections be postponed? Rhinology. 2013; 51 (3): 222–230.

5. Khalfoun S., Tumin D., Ghossein M. et al. Improved Lung function after sinus surgery in cystic fibrosis patients with moderate obstruction. Otolaryngol. Head Neck Surg. 2018; 158 (2): 381–385. DOI: 10.1177/0194599817739284.

6. Macdonald K.I., Gipsman A., Magit A. et al. Endoscopic sinus surgery in patients with cystic fibrosis: a systematic review and meta-analysis of pulmonary function. Rhinology. 2012; 50 (4): 360–369. DOI: 10.4193/Rhin11.271.

7. Liang J., Higgins T.S., Ishman S.L. et al. Surgical management of chronic rhinosinusitis in cystic fibrosis: a systematic review. Int. Forum Allergy Rhinol. 2013; 3 (10): 814–822. DOI: 10.1002/alr.21190.

8. Vlastarakos P.V., Fetta M., Segas J.V. et al. Functional endoscopic sinus surgery improves sinus-related symptoms and quality of life in children with chronic rhinosinusitis: a systematic analysis and meta-analysis of published interventional studies. Clin. Pediatr. (Phila). 2013; 52 (12): 1091–1097. DOI: 10.1177/0009922813506489.

9. Xie D.X., Wu J., Kelly K. et al. Evaluating the sinus and Nasal Quality of Life Survey in the pediatric cystic fibrosis patient population. Int. J. Pediatr. Otorhinolaryngol. 2017; 102: 133–137. DOI: 10.1016/j.ijporl.2017.09.014.

10. Polyakov D.P., Karneeva O.V., Belavina P.I. [Chronic rhinosinusitis in the children presenting with mucoviscidosis: the current trends in diagnostics and treatment]. Rossiyskaya rinologiya. 2018; 26 (4): 17–25. DOI: 10.17116/rosrino20182604117 (in Russian).

11. Ushakova S.G., Belavina P.I., Simonova O.I., Karneeva O.V. [New method of conservative treatment of chronic rhinosinusitis in children with cystic fibrosis]. Voprosy sovremennoy pediatrii. 2010; 9 (5): 72–79. Available at: https://vsp.spr-journal.ru/jour/article/view/952 (in Russian).

12. Gysin C., Alothman G.A., Papsin B.С. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr. Pulmonol. 2000; 30 (6): 481–489. DOI: 10.1002/1099-0496(200012)30:6<481::aidppul8>3.0.co;2-n.

13. ECFS. European Cystic Fibrosis Society Patient Registry. Available at: https://www.ecfs.eu/projects/ecfs-patient-registry/intro [Accessed: 20.01.2021].

14. [Cystic fibrosis: clinical guidelines. 2020]. Available at: https://mukoviscidoz.org/doc/med_doc/klinrec_cistys_fibrosys.pdf (in Russian).

15. Kondratyeva E.I., Voronkova A.Yu., Bobrovnichiy V.I. et al. [Clinical, molecular, and microbiological characteristics of cystic fibrosis patients at Moscow region and Belarus’ Republic]. Pul’monologiya. 2018; 28 (3): 296–306. DOI: 10.18093/0869-0189-2018-28-3-296-306 (in Russian).

16. Polgar G., Promadhat V. Pulmonary function testing in children: Techniques and standards. Philadelphia: W.B.Saunders Co; 1971.

17. Quanjer P.H., Tammeling G.J., Cotes J.E. et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. 1993; 16 (Suppl.): 5–40.

18. Sinaasappel M., Stern M., Littlewood J. et al. Nutrition in patients with cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2002; 1 (2): 51–75. DOI: 10.1016/s1569-1993(02)00032-2.

19. Petrova N.V., Kondratyeva E.I., Krasovskiy S.A. et al. [National Consensus Project “Cystic fibrosis: definition, diagnostic criteria, treatment” Section “Genetics of Cystic Fibrosis. Molecular genetic diagnosis of cystic fibrosis”]. Medicinskaya genetika. 2016; 15 (11): 29–45. Available at: https://www.medgen-journal.ru/jour/article/view/188/165# (in Russian).

20.